16-fluoro-5-androsten-17-one has been researched along with corticosterone in 1 studies
| Studies (16-fluoro-5-androsten-17-one) | Trials (16-fluoro-5-androsten-17-one) | Recent Studies (post-2010) (16-fluoro-5-androsten-17-one) | Studies (corticosterone) | Trials (corticosterone) | Recent Studies (post-2010) (corticosterone) |
|---|---|---|---|---|---|
| 11 | 0 | 1 | 27,121 | 124 | 6,622 |
| Protein | Taxonomy | 16-fluoro-5-androsten-17-one (IC50) | corticosterone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.945 | |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 4.9 | |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pashko, LL; Schwartz, AG | 1 |
1 other study(ies) available for 16-fluoro-5-androsten-17-one and corticosterone
| Article | Year |
|---|---|
Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes.
Topics: Androstenes; Animals; Antineoplastic Agents; Binding, Competitive; Capillary Permeability; Carcinogens; Cations; Corticosterone; Dehydroepiandrosterone; DNA; Epidermis; Female; Free Radicals; Hyperplasia; Inflammation; Liposomes; Mice; NADP; Tetradecanoylphorbol Acetate | 2001 |